BIOVERATIV THERAPEUTICS

BIOVERATIV THERAPEUTICS is a biotechnology service provider dedicated to addressing various issues related to the treatment of chronic blood disorders. The company's biotechnology services include providing treatments for hemophilia, sickle cell disease, and β-thalassemia, as well as conducting clinical trials and research and development of therapeutic methods, enabling medical institutions and patients to access a wide range of scientific treatments to combat life-threatening blood diseases.